相关实验视频
Updated: Jun 29, 2025

06:08
A Novel Method: Super-selective Adrenal Venous Sampling
Published on: September 15, 2017
23.4K
开发一种诊断模型,用于对原发性阿尔多斯特主义进行洗前查
1Department of Cardiology, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 167 North Lishi Road, Beijing, 100037, Xicheng, China.
Journal of endocrinological investigation
|March 27, 2024
概括
一个新的PAPS3模型有助于在没有药物洗的情况下进行一次性阿尔多斯特症查. 这种诊断工具提高了无法忍受停药的患者的效率,提高了诊断准确度.
科学领域:
- 内分泌学 在内分泌学.
- 心血管医学 心血管医学
- 诊断创新是一种创新.
背景情况:
- 抗高血压药物复杂化了原发性阿尔多斯特隆症 (PA) 的诊断.
- 药物清洗通常是必要的,但对许多患者来说具有挑战性.
- 在PA查中存在对替代诊断策略的需求.
研究的目的:
- 开发和验证一种用于PA查的诊断模型,可以绕过药物洗的需要.
- 提供一种更容易获得和更有效的AP诊断方法.
主要方法:
- 对1095名患有PA或基本高血压的患者的回顾性分析.
- 随机训练和验证集 (7:3比例).
- 收集了基线特征,血中阿尔多素度 (PAC) 和直接宁度 (DRC) 在洗前和洗后;计算了阿尔多素与宁的比率 (ARR).
主要成果:
- 与基本高血压患者相比,患有PA的患者表现出更高的PAC和ARR,以及较低的DRC.
- 在,水平和高血压等级上观察到显著的差异.
- 开发了PAPS3模型 (,ARR,PAC,,高血压等级3),截止值为5.5,显示出高灵敏度和特异性.
结论:
- PAPS3模型为PA查提供了一个可行的替代方案,特别是对于不能容忍药物洗的患者.
- 这种方法可以最大限度地降低风险,并提高PA的诊断效率.
- 建议对PAPS3模型进行进一步的大规模验证.
更多相关视频
相关概念视频
Antihypertensive Drugs: Potassium-Sparing Diuretics
534
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
534
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
424
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
424

